ÌÇÐÄÊÓÆµ

Robin Parihar

Parihar

Robin Parihar, M.D., Ph.D.

Assistant Professor

Positions

Assistant Professor
Pediatrics
Hematology-Oncology
ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas
Associate Director
Pediatric Hematology/Oncology Fellowship Program
ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas
Faculty Member
Center for Cell and Gene Therapy
ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas
Research Member
Dan L Duncan Comprehensive Cancer Center
ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas
Faculty Member
Immunology and Microbiology
Graduate School of Biomedical Sciences
ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas
Faculty Member
Development, Disease Models, and Therapeutics
Graduate School of Biomedical Sciences
ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas

Addresses

Texas Children's Hospital, Mark Wallace Tower (Clinic)
6701 Fannin St
14th floor
Houston, TX, 77030
United States
Phone: (832) 822-4242

Certifications

Board Certified
American Board of Pediatrics
Pediatric Hematology-Oncology
Fellow (FAAP)
American Academy of Pediatrics
Board Certified
American Board of Pediatrics
General Pediatrics

Professional Interests

  • Pediatric solid tumors
  • Solid tumor microenvironment
  • Natural Killer (NK) cell biology
  • Cellular therapies for solid tumors

Professional Statement

I am a pediatric oncologist with an interest in caring for children with solid tumors. I have an active research lab interested in stimulating the immune system to fight solid tumors. My lab investigates the role of a specific type of immune cell called the natural killer (NK) cell in the control of cancer. My current research projects aim to enhance NK cell function in order to target the tumor microenvironment, essentially getting rid of the accessory cells that help a tumor resist standard therapies. I am currently working on introducing the enhanced NK cells as therapy for children with advanced cancers. In addition, we are using our established lab models to better understand how the tumor microenvironment suppresses the immune system, in order to develop new approaches to overcome this inhibition and improve immune-based therapies for pediatric cancers.

Websites

Selected Publications

  • Navin, I., Dysthe, M., Menon, P.S., Baumgartner, C., Sauer, T., Varadarajan, N., and Parihar, R. " " Can Immunol Res. 2025 Jul 30;
    Pubmed PMID: .
  • Dysthe, M., Navin, I., van Leeuwen, D., Pineda, J., Baumgartner, C., Rooney, C.M., and Parihar, R.. " " J Immunother Cancer. 2025 Jul 23;
    Pubmed PMID: .
  • Navin, I., Lam, M.T., and Parihar, R.. " " Cancers. 2020 Dec 21; 12 (12) : 3871-79..
    Pubmed PMID: .
  • Devkota, L., Starosolski, Z., Rivas, C.H., Stupin, I., Annapragada, A., Ghaghada, K.B., and Parihar, R.. " " Science Advances. 2020 Jul 10; 6 (eaba6156.)
    Pubmed PMID: .

to edit your profile